We are live on ! Find out more
HGEN

HUMANIGEN, INC.
HGEN

Delisted

HGEN was delisted on the 25th of July, 2023.

Back to rankings

42 hedge funds and large institutions have $669K invested in HUMANIGEN, INC. in 2023 Q1 according to their latest regulatory filings, with 4 funds opening new positions, 7 increasing their positions, 12 reducing their positions, and 9 closing their positions.

New
Increased
Maintained
Reduced
Closed

2.06% less ownership

Funds ownership: 5.98% → 3.93% (-2.1%)

13% less funds holding

Funds holding: 48 → 42 (-6)

22% less capital invested

Capital invested by funds: $858K → $669K (-$189K)

42% less repeat investments, than reductions

Existing positions increased: 7 | Existing positions reduced: 12

56% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 9

Holders
42
Holders Change
-6
Holders Change %
-12.5%
% of All Funds
0.67%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
7
Reduced
12
Closed
9
Calls
$8K
Puts
–
Net Calls
+$8K
Net Calls Change
-$5K

Top Buyers

Rank Fund Capital Flow
1
UBS Group
UBS Group
Switzerland
+$18.7K
2
BlackRock
BlackRock
New York
+$12.7K
3
Two Sigma Investments
Two Sigma Investments
New York
+$11.1K
4
CAPTRUST Financial Advisors
CAPTRUST Financial Advisors
North Carolina
+$9.76K
5
Northern Trust
Northern Trust
Illinois
+$9.12K

Top Sellers

Rank Fund Capital Flow
1
Renaissance Technologies
Renaissance Technologies
New York
-$223K
2
VF
Virtu Financial
New York
-$36K
3
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$23K
4
Citadel Advisors
Citadel Advisors
Florida
-$17.7K
5
Millennium Management
Millennium Management
New York
-$17K

HGEN Hedge Fund Activity: Q1 2023 in Review

42 of the 6,283 institutional investors tracked by Wall St. Rank reported a position in HUMANIGEN, INC. (HGEN) for Q1 2023, worth a combined $669K — down 22% from $858K a quarter earlier.

Sellers outnumbered buyers: 9 funds closed out of HGEN and 4 opened new positions — a net loss of 5 holders — while 12 trimmed existing stakes and 7 added.

The largest buyer was UBS Group, adding an estimated $18.7K. The largest seller was Renaissance Technologies, cutting an estimated $223K.

  • 42 institutional investors held HUMANIGEN, INC. (HGEN) as of Q1 2023, down from 48 in Q4 2022.
  • Funds reported $669K of HUMANIGEN, INC. stock for Q1 2023, down 22% quarter-over-quarter.
  • 4 funds opened new HUMANIGEN, INC. positions in Q1 2023 and 9 closed out, a net change of -5 holders.
  • The largest HUMANIGEN, INC. buyer in Q1 2023 was UBS Group, an estimated $18.7K added.
  • The largest HUMANIGEN, INC. seller in Q1 2023 was Renaissance Technologies, an estimated $223K sold.

Based on aggregated 13F filings for Q1 2023.